Showing 4991-5000 of 5696 results for "".
- Ziemer Receives CE Mark Clearance For Two New Applications For the Femto LDV Z8 Laser Platformhttps://modernod.com/news/ziemer-receives-ce-mark-clearance-for-two-new-applications-for-the-femto-ldv-z8-laser-platform/2477654/After several years of development, Ziemer has received CE clearance for its new lenticule application called CLEAR (Corneal Lenticule Extraction for Advanced Refractive Correction). The new proprietary application is
- WHO Accidently Leaks Disappointing Results of Chinese Clinical Trial Testing Gilead’s Remdesivir in Severe COVID-19https://modernod.com/news/who-accidently-leaks-disappointing-results-of-chinese-clinical-trial-testing-gileads-remdesivir-in-severe-covid-19/2477645/According to a draft document published in error by the World Health Organization (WHO), Gilead Sciences’ remdesivir failed to improve the condition of patients with severe COVID-19 participating in a Chinese clinical trial, nor was the drug found to reduce the virus’ presence in the
- COVID-19 Vaccine Protects Monkeys From New Coronavirus, Chinese Biotech Reportshttps://modernod.com/news/covid-19-vaccine-protects-monkeys-from-new-coronavirus-chinese-biotech-reports/2477646/For the first time, one of the many COVID-19 vaccines in development has protected an animal, rhesus macaques, from infection by the new coronavirus, according to a
- Ambulatory Surgery Centers Eligible For New Relief Grant Fundshttps://modernod.com/news/ambulatory-surgery-centers-eligible-for-new-relief-grant-funds-on-april-24/2477642/The Department of Health and Human Services (HHS) announced that, commencing April 24, health care providers, including ASCs, will be eligible to receive grants from a newly available pool of COVID-19 relief funds, according to The Outpatient Ophthalmic Surgery Society (OOSS). These grants are a
- Lancet Neurology Publishes Pivotal Phase 3 Data for Genentech’s Satralizumab for NMOSDhttps://modernod.com/news/lancet-neurology-publishes-pivotal-phase-3-data-for-genentechs-satralizumab-for-nmosd/2477640/Lancet Neurology published full pivotal phase 3 clinical data on investigational medicine satralizumab as a monotherapy for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating central nervous system disease that is commonly misdiagnosed as multiple scler
- Johnson & Johnson Vision Appoints Rajesh K. Rajpal, MD, Chief Medical Officerhttps://modernod.com/news/johnson-johnson-vision-appoints-rajesh-k-rajpal-md-chief-medical-officer/2477634/Johnson & Johnson Vision has appointed Rajesh K. Rajpal, MD, as Chief Medical Officer and Global Head of Clinical and Medical Affairs. In this role, Dr. Rajpal will lead the integration of rapidly evolving medical and clinical insights into new product development to address unmet needs of pa
- Regenxbio Announces Additional Positive Long-Term and Interim Phase 1/2a Trial Update for RGX-314 for the Treatment of Wet AMDhttps://modernod.com/news/regenxbio-announces-additional-positive-long-term-and-interim-phase-1-2a-trial-update-for-rgx-314-for-the-treatment-of-wet-amd/2477630/Regenxbio provided additional long-term data from the ongoing phase 1/2a trial of RGX-314 for the treatment of wet age-related macular degeneration (AMD). In the phase 1/2a trial of RGX-314, 42 patients with severe wet AMD requiring frequent anti-vascular endothelial growth factor (anti-VE
- How Does Coronavirus Kill? Clinicians Trace a Ferocious Rampage Through the Bodyhttps://modernod.com/news/how-does-coronavirus-kill-clinicians-trace-a-ferocious-rampage-through-the-body/2477615/As the number of confirmed cases of COVID-19 surges past 2.2 million globally and deaths surpass 150,000, clinicians and pathologists are struggling to understand the damage wrought by the coronavirus as it tears through the body. They are realizing that although the lungs are ground zero, its re
- AAO Releases Statement Addressing the Reopening of Ophthalmology Carehttps://modernod.com/news/aao-releases-statement-regarding-returning-to-ophthalmology-practice/2477611/In a letter to its membership, American Academy of Ophthalmology (AAO) CEO David W. Parke II, MD, stated that now is the time to consider the process of reopening ophthalmology care—on a local
- Haag-Streit Group Acquires Majority Stake in VRmagichttps://modernod.com/news/haag-streit-group-acquires-majority-stake-in-vrmagic/2477610/In an effort to expand medical training for ophthalmologists, Haag-Streit announced that it has acquired a majority stake in VRmagic. VRmagic was established in 2001 and is a pioneer for virtual and augmented reality technology in medical training. The solutions developed by VRmagic permit